AKT1 and lung cancer: ,50 Our results indicate that the drugs induce the increase of labile Zn2+ in lung cancer cells, leading to an increase in AKT phosphorylation to upregulate ABCB1 at protein expression level, and to ATP production that enables ABCB1 to obtain more energy at the metabolic level.